Case Report
Possible Iodine-Induced Thyrotoxicosis in a Previously Healthy Adolescent following Administration of Iodinated Contrast Media
| | 12/28/17+ | 2/23/20 PCD 4 | 2/24/20 PCD 5 | 2/27/20 PCD 8 | 2/28/20 PCD 9 | 2/29/20 PCD 10 | 3/1/20 PCD11 | 3/6/20 PCD16 | 3/11/20 PCD 21 |
| TSH (uIU/ml) 0.6–4.8 | 1.165 | <0.0008 | <0.0008 | 0.0009 | 0.008 | 0.009 | 0.008 | 0.011 | 0.822 | Free T4 (ng/dL) 0.9–1.8 (ng/dL) | 1.0 | 4.1 | 5.1 | 6.8 | 7.4 | 7.0 | 5.2 | 2.4 | 1.3 | Total T4 (ug/dL) 4.5–10.9 | | 15.0 | 16.5 | 26.9 | 26.3 | 24.7 | 21.5 | 8.1 | 6.4 | Total T3 (ng/mL) 0.6–1.8 | | 1.79 | 1.81 | 4.06 | 3.90 | 2.76 | 1.91 | 0.76 | 1.00 | TSI (IU/L) <0.54IU/L | | | <0.10 | | | | | | | TPO ab (IU/ml) 0.0–9.0 | | | <0.3 | | | | | | | Tg ag (IU/ml) 0.0–4.0 | | | <0.9 | | | | | | |
|
|
PCD: Post contrast day, +available as baseline from prior GI appointment for poor weight gain, methimazole started, hydrocortisone 100 mg q 8/propranolol 40 mg q 8 hours started, methimazole stopped/Hydrocortisone stopped, propranolol stopped. |